Characteristics of Patients Studied and Treatment Given
| Patient no. | Sex | Age (y) | Tumor type | No. of treatments | Total activity (GBq) | Duration of treatment (mo) |
|---|---|---|---|---|---|---|
| 1 | F | 46 | MCT | 4 | 11.4 | 12 |
| 2 | M | 71 | Carcinoid | 5 | 15.2 | 15 |
| 3 | M | 47 | Carcinoid | 10 | 36.6 | 30 |
| 4 | F | 32 | Carcinoid | 5 | 18.1 | 15 |
| 5 | F | 34 | Carcinoid | 9 | 33.6 | 28 |
| 6 | M | 48 | Carcinoid | 1 | 3.1 | N/A |
| 7 | M | 32 | Carcinoid | 4 | 16.7* | 5 |
| 8 | F | 53 | Gastrinoma | 4 | 12.5 | 12 |
| 9 | F | 76 | Carcinoid | 8 | 24.4 | 20 |
| 10 | F | 54 | Carcinoid | 7 | 21.1 | 18 |
| 11 | M | 58 | MCT | 3 | 10.5* | 4 |
| 12 | M | 71 | Carcinoid | 4 | 14.8* | 5 |
| 13 | M | 61 | Glucagonoma | 3 | 11.6* | 10† |
| 14 | M | 55 | Carcinoid | 5 | 23.0* | 10 |
| 15 | M | 32 | Fibrolamellar | 3 | 12.2* | 3 |
| 16 | F | 58 | Malignant histiocytoma | 1 | 7 | 1 |